Authors


Ruby Madison Ford

Latest:

Assessing Sponsor Attitudes Toward Retail Pharmacy Involvement in Clinical Trial Recruitment and Execution

Amid CVS’ surprise exit from the clinical research space and the ensuing broader questions, study investigates the benefits of pharmacy chain involvement—along with the concerns and barriers to adoption.


Brian Ongioni

Latest:

Consent Management: Moving Beyond Simple eConsent

Providing patients with more flexibility in how they choose to participate in trials.


Ana Cosme, PhD

Latest:

Consequences of Brexit for Clinical Trials in Europe

Higher costs headline list of new challenges faced by CROs and sponsors.


Donna Hanson

Latest:

Optimizing Patient Recruitment and Engagement Strategies

Five strategies to reduce risk and achieve deadlines.


Priyanka Sawant

Latest:

Fast Track Implementation of eConsent: COVID-19 Paves the Way for Virtual Trials

As many countries slowly progress with the “New Normal,” researchers and healthcare providers are assessing digital/virtual approaches that could reinstate clinical trials.


Brian S. McGowan, PhD, FACEHP

Latest:

Can We Predict Trial Success? From ‘Feasibility’ to Predictive ‘Readiness’

What learning science has taught us about the drivers and predictors of change—and applying those to clinical research practice.


Younes Benjeaa

Latest:

Gender Bias in the Clinical Evaluation of Drugs

Past decades have shown gender-based differences in clinical trial results are often overlooked when considering safety and effectiveness.


Bianca Piachaud-Moustakis

Latest:

Accelerating Clinical Trials in the EU

The ACT EU initiative aims to develop the European Union further as a competitive center for innovative clinical research.


Ann Heidger

Latest:

Innovating Beyond the Lab: The Critical Role of Contracting in Research

Biotechs can successfully overcome bottlenecks in time-to-market for new drugs by embracing contracting innovations with the same passion applied to research breakthroughs.


KORE

Latest:

The Problem with Decentralized Clinical Trials and How to Solve for Success

Wed, Sep 7, 2022 11:00am EST | 8:00am PST | 4pm BST | 5:00pm CEST Decentralized Clinical Trials (DCT) is one of the hottest buzzwords in Life Sciences and Connected Health organizations today. Like any new approach, challenges and roadblocks are common and knowing how to solve for them will empower your organization to accelerate your trial deployment, speeding return of results and time to market.


Judy Narisi, RN, BSN

Latest:

Pitfalls to Avoid with Clinical Adjudication

Involvement of clinical endpoint committees in the adjudication process can improve reliability and robustness of data.


Jane Snowdon

Latest:

Characterizing Clinical Data Management Challenges and Their Impact

2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.


Ravi Karra, MD

Latest:

Optimizing Drug Development for Solid Tumors: Leveraging Innovative Trial Designs and Advanced Imaging Techniques

How innovative trial designs and advanced imaging modalities can address the challenges of early drug development to optimize outcomes for patients with solid tumors.



Ping-Chung Chang

Latest:

‘Upskilling’ Your Workforce to Keep Pace with Change

The DCT-driven evolution requires new levels of understanding and expertise.


Stephen Raymond, PhD

Latest:

Considering Patient Burden in Oncology

Implementing new strategies with the use of patient-reported outcomes.


Robert Howie

Latest:

An Examination of the Role of the Clinical Research Associate and Factors Impacting Performance and Experience

Study by Tufts CSDD uncovers potential reasons behind CRA shortages, turnover, experience requirements, and more.


Alex Gee, Senior Director, Pricing & Market Access Parexel

Latest:

Four Key Trends for Identifying Regulator and Payer Evidence Needs in Oncology Drug Development

How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.



Patricia Dewaele

Latest:

Clinical Study Audits: The Quality Management Approach

Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.


Sarah Lyons

Latest:

Sharing Anonymized and Functionally Effective (SAFE) Data Standard for Safely Sharing Rich Clinical Trial Data

Presenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.


Craig McLendon

Latest:

DMCs: Maintaining Data Integrity in COVID-19 Climate

Regulators are urging the use of data monitoring committees to support clinical trial management and decision-making during pandemic.


Francis Pollaro

Latest:

Q&A With Daniel Lofaso, CEO of Digital Elevator

In this Q&A with Applied Clinical Trials' sister brand, Pharmaceutical Executive, Lofaso discusses marketing strategies for early-stage biotech companies, including how they can effectively recruit patients for their clinical trials.


Chuck Drucker

Latest:

At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device

Laboratory services organization focuses on easing patient and site burden with improved collection device.


Luk Arbuckle

Latest:

Establishing a Basis for Secondary Use Standards for Clinical Trials

Study seeks to understand how different forms of data meet the needs of researchers.


Tony Southers

Latest:

Blending Models for Better Sourcing Solutions

CRO-sponsor relationships are key as industry moves towards new age of outsourcing.


Anthony Everhart, MD

Latest:

Optimal COA Measurement Strategy in Modern Oncology Trials

Examining the two areas of weakness cited in FDA draft guidance.


Patricia Davidson

Latest:

Introducing PALADIN

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.


Nurul Atiqah Binti Abd Rahman

Latest:

Managing Clinical Trial Agreements

How Clinical Research Malaysia sped up CTA turnaround using a web-based system.


Jai Seth

Latest:

Getting to Clinical Trial Diversity

Differing levels of trust in clinical trials information channels across diverse populations is examined in this research.

© 2024 MJH Life Sciences

All rights reserved.